Depression Clinical Trials in San Francisco, California

3 studies are recruiting for depression in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Psilocybin Therapy for Depression in Parkinson's Disease

   The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.

   Stage

   Phase 2

   Ages

   40 to 80

   Site

   University of California, San Francisco, San Francisco, California

   Run by

   Joshua Woolley, MD, PhD

   See if you can join NCT06455293 on ClinicalTrials.gov

2. E-Mindfulness Approaches for Living After Breast Cancer

   NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants wi…

   Stage

   Phase 3

   Ages

   18 to 50

   Site

   Kaiser Permanente-San Francisco, San Francisco, California

   Locations

   383 in total

   Run by

   NRG Oncology

   See if you can join NCT06748222 on ClinicalTrials.gov

3. Probiotic Administration for Adolescent Depression

   This double-blind, placebo-controlled clinical trial will examine the effect of probiotic Visbiome on the brain and gut microbiome of individuals 15 to 24 years of age.

   Stage

   EARLY_Phase 1

   Ages

   15 to 24

   Site

   UCSF, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT06898788 on ClinicalTrials.gov